Company Description
Bayhill Therapeutics wants to make it all better. The clinical-stage biopharmaceutical company develops products to treat autoimmune diseases. Its...
Key Bayhill Financials
| Company Type | Private - NASDAQ (GM): BHTX Proposed Main Headquarters |
|---|---|
| 2006 Sales (mil.) | $0.0 |
| 2006 Employees | 39 |
More Bayhill Financials (4 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Bayhill's competition across multiple industries
Top Bayhill Competitors
Sponsored Links
The Business Directory
Bayhill Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| VP Business Development | Paul Westberg | Network | E-mail |
| President, CEO, and Director | Mark W. Schwartz | Network | E-mail |
| CFO | Fred Kurland | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Bayhill News
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.